Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.
Gynecol. Oncol., Dec;127(3):451-5 (2012)
A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group trial.
Int. J. Gynecol. Cancer., Oct;20(7):1137-41 (2010)
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.
Gynecol. Oncol., Sep;118(3):303-7 (2010)
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol. Oncol., Aug;118(2):139-44 (2010)
Pain evaluation in patients receiving intravenous patient-controlled analgesia after surgery.
Pharmacotherapy., Sep;25(9):1168-73 (2005)
Analgesic and hemodynamic effects of a single 7.5-mg intravenous dose of morphine in patients with moderate-to-severe postoperative pain.
Pharmacotherapy., Dec;24(12):1675-80 (2004)
Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Clin. Cancer Res., Nov;4(11):2577-83 (1998)
Interstitial pregnancy complicated by rectal bleeding.
Am. J. Obstet. Gynecol., Nov;175(5):1373-5 (1996)
Colposcopic biopsies versus loop electrosurgical excision procedure cone histology in human immunodeficiency virus-positive women.
J Reprod Med., Sep;41(9):653-7 (1996)
Adrenal function following high-dose steroids in ovarian cancer patients.
Gynecol. Oncol., Oct;59(1):102-4 (1995)
Recurrent mild abruptio placentae occurring immediately after repeated electroconvulsive therapy in pregnancy.
Am. J. Obstet. Gynecol., Sep;165(3):652-3 (1991)
Endometrial carcinoma: the relevance of cervical cytology.
Obstet Gynecol., Mar;77(3):458-62 (1991)